Wang Bao Ming - Net Worth and Insider Trading
Wang Bao Ming Net Worth
The estimated net worth of Wang Bao Ming is at least $20 Million dollars as of 2024-11-08. Wang Bao Ming is the senior management of Tibet Rhodiola Pharmaceutical Holding Co and owns about 500,500 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $20 Million. Details can be seen in Wang Bao Ming's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Bao Ming has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wang Bao Ming
Wang Bao Ming Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wang Bao Ming owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Wang Bao Ming’s form 4 insider trades.
Insider Ownership Summary of Wang Bao Ming
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | senior management |
Wang Bao Ming Latest Holdings Summary
Wang Bao Ming currently owns a total of 1 stock. Wang Bao Ming owns 500,500 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $20 Million.
Latest Holdings of Wang Bao Ming
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 500,500 | 40.14 | 20,090,070 |
Holding Weightings of Wang Bao Ming
Wang Bao Ming Form 4 Trading Tracker
According to the SEC Form 4 filings, Wang Bao Ming has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 500,500 shares on January 25, 2008, which brought Wang Bao Ming around $1 Million.
Insider Trading History of Wang Bao Ming
- 1
Wang Bao Ming Trading Performance
GuruFocus tracks the stock performance after each of Wang Bao Ming's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Bao Ming is -40%. GuruFocus also compares Wang Bao Ming's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Bao Ming within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wang Bao Ming's insider trading performs compared to the benchmark.
Performance of Wang Bao Ming
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Wang Bao Ming Ownership Network
Ownership Network List of Wang Bao Ming
Ownership Network Relation of Wang Bao Ming
Wang Bao Ming Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Wang Bao Ming is the senior management of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Cao Shu Zhen , Supervisors Ren Bei Chen , and Supervisors Liu De Gong .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Wang Bao Ming Mailing Address
Above is the net worth, insider trading, and ownership report for Wang Bao Ming. Currently GuruFocus does not have mailing address information for Wang Bao Ming.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
